N@N

SSD, WOOF, PDFS, ITMN, FFCH, GERN Expected To Be Down After Next Earnings Releases

^{Published on 2011-07-27 07:02:04 - WOPRAI}
 

July 27, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, July 28th 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and June earnings reports. SIMPSON MANUFACTURING CO INC (NYSE:SSD), VCA ANTECH INC (NASDAQ:WOOF), PDF SOLUTIONS INC (NASDAQ:PDFS), INTERMUNE, INC. (NASDAQ:ITMN), FIRST FINANCIAL HOLDINGS INC (NASDAQ:FFCH), GERON CORPORATION (NASDAQ:GERN) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Thursday:

     Symbol     Company                             # of Reports            Quarter     Release Time
     SSD        SIMPSON MANUFACTURING CO INC        6 Quarter               Q2          After
     WOOF       VCA ANTECH INC                      12 Quarter              Q2          After
     PDFS       PDF SOLUTIONS INC                   6 Quarter               Q2          After
     ITMN       INTERMUNE, INC.                     12 Quarter              Q2          After
     FFCH       FIRST FINANCIAL HOLDINGS INC        6 Quarter               Q3          After
     GERN       GERON CORPORATION                   12 Quarter              Q2          After

SIMPSON MANUFACTURING CO INC (NYSE:SSD) - Simpson Manufacturing Co., Inc., through its subsidiaries, engages in the design, engineering, manufacture, and sale of building products. The company offers wood-to-wood, wood-to-concrete, and wood-to-masonry connectors; screw fastening systems and collated screws; stainless steel fasteners; and pre-fabricated shear walls. It also provides adhesives, mechanical anchors, carbide drill bits, and powder actuated tools for concrete, masonry, and steel markets. Simpson Manufacturing Co. markets its products for the residential construction, light industrial and commercial construction, remodeling, and do-it-yourself markets in the United States, Europe, Canada, Asia, Australia, New Zealand, Mexico, and other countries in central and South America and the Middle East. It distributes its products to home centers through wholesale distributors, contractors and dealers, and original equipment manufacturers. The company was founded in 1956 and is based in Pleasanton, California.

VCA ANTECH INC (NASDAQ:WOOF) - vca Antech Inc.s, Laboratory segment provides veterinary services and diagnostic testing through its network of 33 laboratories in 50 states that provide testing and consulting services to veterinarians. The Animal Hospitals segment operates 379 freestanding, full-service animal hospitals in 37 states offering specialized treatments and pet wellness programs. vca Antechs Medical Technology segment sells ultrasound and digital radiography imaging equipment and provides related computer hardware, software, and consulting and training services, as well as mobile diagnostic ultrasound imaging services. vca Antech was founded in 1986 and is headquartered in Los Angeles.

PDF SOLUTIONS INC (NASDAQ:PDFS) - PDF Solutions, Inc. provides infrastructure technologies and services for the design and manufacture of integrated circuits(IC) in Asia, the United States, and Europe. It offers manufacturing process solutions that include process research and development, and process integration and yield ramp; volume manufacturing solutions; and design-for-manufacturability (DFM) solutions, such as logic DFM, circuit level DFM, memory DFM, and pdBRIX Physical IP solutions. The company also offers characterization vehicle (CV) infrastructure, which includes CV test chips, pdCV analysis software, and pdFasTest electrical wafer test system; Yield Ramp Simulator software that analyzes an IC design to compute its systematic and random yield loss; and Circuit Surfer software, which estimates the parametric performance yield and manufacturability of analog/mixed-signal/radio frequency blocks. In addition, it provides pdBRIX platform, which includes software for identifying and developing a set of physical IP building blocks that are tailored to a given manufacturing process and target product application; dataPOWER YMS platform that collects yield data, loads, and stores it in an integrated database and allows product engineers to identify and analyze production yield issues; maestria FDC software, which provides fault detection and classification capabilities to identify sources of process variations and manufacturing excursions by monitoring equipment parameters; and YA-FDC service and software platform that allows online modeling to create real-time virtual measurements of final product attributes during processing. PDF Solutions sells its technologies and services through direct sales force, sales representatives, and strategic alliances to integrated device manufacturers, fables semiconductor design companies, and foundries. The company was founded in 1992 and is headquartered in San Jose, California.

INTERMUNE, INC. (NASDAQ:ITMN) - InterMune, Inc., a biotech company, focuses on developing and commercializing therapies in pulmonology and hepatology primarily in the United States and Europe. The company primarily offers Actimmune for the treatment of patients with severe, malignant osteopetrosis, and chronic granulomatous disease. Its pulmonology product portfolio includes lead product candidate, pirfenidone, a phase III product being developed for the treatment of patients with idiopathic pulmonary fibrosis; and a research program focused on small molecules for pulmonary diseases. The companys hepatology portfolio comprises the HCV protease inhibitor RG7227, a phase IIb chronic hepatitis C program and an early stage research program evaluating a new target in hepatology. It has license and collaboration agreements with Genentech, Inc.; Boehringer Ingelheim International GmbH; Connetics Corporation; and Novartis Corporation. The company was founded in 1998 and is headquartered in Brisbane, California.

FIRST FINANCIAL HOLDINGS INC (NASDAQ:FFCH) - First Financial Holdings, Inc. operates as the holding company for First Federal Savings and Loan Association of Charleston that provides various banking and other related financial services. Its deposit products include demand deposit transaction accounts, time deposit accounts, non-interest-bearing checking accounts, interest-bearing checking accounts, savings accounts, money market accounts, individual retirement accounts, and certificates of deposits. The companys loan portfolio comprises residential real estate mortgage and construction loans, commercial and multifamily real estate mortgage loans, home equity, manufactured housing, and other consumer loans; credit card receivables; and commercial business loans. As of September 30, 2009, it operated 44 full service retail branch sales offices, 18 in-store retail branch sales offices, and 3 limited services branches in Charleston, Berkeley, Dorchester, Hilton Head area of Beaufort, Georgetown, Horry, and Florence Counties, South Carolina; and Brunswick, New Hanover, and Pender Counties, North Carolina. First Financial Holdings, Inc., through its other subsidiaries, engages in full-service brokerage activities; property, casualty, life, and health insurance sales; third party administrative services, including services to retirement plans; trust and fiduciary services; reinsurance of private mortgage insurance; and premium finance activities. The company was founded in 1987 and is headquartered in Charleston, South Carolina.

GERON CORPORATION (NASDAQ:GERN) - Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes. It develops a range of anti-cancer therapies based on telomerase inhibitors and telomerase therapeutic vaccines; and diagnostics based on telomerase detection, as well as intends to develop products using telomerase as a marker for cancer diagnosis, prognosis, patient monitoring, and screening. The company develops Imetelstat (GRN163L), which is in Phase I clinical trial for the treatment of chronic lymphoproliferative diseases, solid tumors, multiple myeloma, and non-small cell lung cancer. GRN163L is also in Phase I/II clinical trial to treat breast cancer. The company also develops GRNVAC1 that is in Phase II clinical trial for the treatment of acute myelogenous leukemia. It also develops GRNOPC1, which is in Phase I Trial for treatment of spinal cord injury; and GRNCM1 that is in preclinical stage to treat heart disease and screening. The company has licensing agreement with Merck & Co. to develop telomerase cancer vaccine, which is in Phase I clinical trial for the treatment of prostate and solid tumors; Sienna Cancer Diagnostics to develop a preclinical stage product for the treatment of bladder cancer; and has a collaboration with the University Campus Suffolk to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease. Geron Corporation was founded in 1990 and is based in Menlo Park, California.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641